• linkedin
  • Increase Font
  • Sharebar

    New Products: Single-use ureteroscope, new FDA Approvals for RCC treatment, and an App that helps IC, chronic prostatitis patients




    Single-use ureteroscope addresses shortcomings of reusable scopes

    Marlborough, MA—Boston Scientific Corp. announced the launch of the LithoVue Single-Use Digital Flexible Ureteroscope for minimally invasive endoscopic procedures to diagnose and treat stones and other conditions of the kidney, ureter, and bladder. The LithoVue system, cleared for marketing by the FDA under the 510(k) regulatory process, is designed to address the inconsistent performance, operational challenges, and costs associated with reusable scopes. It delivers high-quality digital visualization and seamless navigation for consistent clinical performance, according to Boston Scientific. Features include a digital CMOS imager in the 7.7F tip with a working distance of 2- to 50-mm for high-quality images; 270Ëš scope deflection in both directions to provide accurate navigation toward the targeted treatment area; workstation monitor with integrated image processing software mounted on a compact, rolling mobile cart that can be used alone during a ureteroscopic procedure or connected to existing monitors and integrated video systems in the operating room suite.

    For more information, visit www.bostonscientific.com/lithovue.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available